The dystrophin-glycoprotein complex in the prevention of muscle damage.
about
Molecular and cell-based therapies for muscle degenerations: a road under constructionCurrent and emerging treatment strategies for Duchenne muscular dystrophyAge-related alterations in the sarcolemmal environment are attenuated by lifelong caloric restriction and voluntary exerciseAbnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy.Incidence and severity of myofiber branching with regeneration and aging.New pathobiochemical insights into dystrophinopathy from the proteomics of senescent mdx mouse muscleImmobilization and therapeutic passive stretching generate thickening and increase the expression of laminin and dystrophin in skeletal muscleSelective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx miceDystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies.Genome-Wide Association Study Identification of Novel Loci Associated with Airway Responsiveness in Chronic Obstructive Pulmonary DiseaseProfiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathyGenetic overexpression of Serpina3n attenuates muscular dystrophy in mice.Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.Distribution of myosin heavy chain isoforms in muscular dystrophy: insights into disease pathology.Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.Thrombospondin expression in myofibers stabilizes muscle membranes.What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?Dietary Flaxseed Mitigates Impaired Skeletal Muscle Regeneration: in Vivo, in Vitro and in Silico Studies.Possible local stem cells activation by microcurrent application in experimentally injured soleus muscle.A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve quality of life in muscular dystrophy patients.Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.Combined XIL-6R and urocortin-2 treatment restores MDX diaphragm muscle force.Effect of voluntary physical activity initiated at age 7 months on skeletal hindlimb and cardiac muscle function in mdx mice of both genders.Attenuation of autophagy impacts on muscle fibre development, starvation induced stress and fibre regeneration following acute injury.Role of the Extracellular Matrix in Muscle Injuries: Histoarchitectural Considerations for Muscle InjuriesCell Transplantation and “Stem Cell Therapy” in the Treatment of Myopathies: Many Promises in Mice, Few Realities in Humans
P2860
Q24568176-7C472031-6943-4924-BB95-AD2C5ACEBD1CQ26741535-56C5E10E-4026-49E5-B7FC-22C4C030A3D2Q28389514-8A06D476-80A4-4EAB-BAE0-DB4DEE2472D9Q30653577-AD2A8D39-994F-4CDF-9479-A7A4D007F465Q33646492-C643CC47-52F3-46AF-929D-FA4201F84E92Q33703934-AFB6D2E9-14A0-42AB-9C9A-3D1EA86B1326Q33861017-36518315-2114-4D3C-8518-B98E9A62FA9AQ33925571-6730D6FA-08DC-458A-B7D6-F316C3717E1CQ35749826-BDD984A1-2AF3-4771-990B-A084AC6B3CBFQ36049194-B32C5425-9244-4D0B-B90B-1649D9D7D080Q36316393-3361DB9D-2A74-4781-8B0A-C4C400A24359Q36608879-66261893-CF07-4787-BD4F-A88E38F8DE9AQ36876302-F7F6EB5D-6272-498F-ADD6-215BFF55CB6CQ37092116-2FD83819-7D51-4FE4-ABD3-06FF2EA2B233Q37111473-B6D6AB73-01D0-4814-85DE-EFA49CD83163Q37338168-B99C194D-D61F-4551-A1B5-71CEB8F44585Q38351283-4915B8E5-845A-4C1D-9D0E-D91033EEF8CDQ38704564-6D559AB7-97B9-4778-9D17-31BE32D3E8B2Q43046325-4863259D-6827-4530-81F6-93EB0CDE11F8Q46767735-B26597C4-1971-4FA8-9F0C-B749B528DCFCQ47324398-EC18B0F0-DC6A-42B8-A488-5F815120DD0CQ47325217-55419B84-7108-4C4E-949A-0BB72A5BC2FDQ47949346-3AB8E318-95CF-4886-BF62-15C9D53A448AQ51052788-651B05CC-8C01-484D-8446-3CD614CA5A79Q55309450-0E266AFB-C9CA-45B3-A7F1-3B0ACFA975A3Q58725785-DB1ACA4B-52C4-47BB-8E88-EA33AF5561D2Q58997812-021A9239-1EC8-4CBE-8020-7DF911402793
P2860
The dystrophin-glycoprotein complex in the prevention of muscle damage.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@en
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@nl
type
label
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@en
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@nl
prefLabel
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@en
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@nl
P2860
P921
P356
P1476
The dystrophin-glycoprotein complex in the prevention of muscle damage.
@en
P2093
Daniel E Michele
Jessica D Gumerson
P2860
P304
P356
10.1155/2011/210797
P577
2011-10-05T00:00:00Z